The future of scoliosis diagnosis lies in the genetic make-up of the patient. Recently, a series of DNA markers has been associated with some forms of idiopathic scoliosis. If we can use those markers, we can further investigate those without the genes for the comorbid conditions listed above. New techniques for management of scoliosis continue to be developed, including attempts at growth modulation instead of direct spinal fusion, which may prove to be useful in the management of very young patients.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.
Pediatr Health. 2009;3(5):451-456. © 2009 Future Medicine Ltd.
Cite this: Scoliosis in Pediatric Patients: Comorbid Disorders and Screening - Medscape - Oct 01, 2009.